Xiaotong Wei
No. 76 Yanta West Road
Xi'an, 710061, China
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Corrigendum to "Erythropoietin ameliorates cognitive dysfunction in mice with type 2 diabetes mellitus via inhibiting iron overload and ferroptosis" [Experimental Neurology, volume 365, 2023) 1-13/114414].
Journal: Experimental neurology
Published: July 12, 2026
Correction: Erythropoietin mitigates diabetic nephropathy by restoring PINK1/Parkin-mediated mitophagy.
Journal: Frontiers in pharmacology
Published: January 06, 2026
Baicalein Ameliorates Insulin Resistance of HFD/STZ Mice Through Activating PI3K/AKT Signal Pathway of Liver and Skeletal Muscle in a GLP-1R-Dependent Manner.
Journal: Antioxidants (Basel, Switzerland)
Published: September 03, 2024
Baicalein: A potential GLP-1R agonist improves cognitive disorder of diabetes through mitophagy enhancement.
Journal: Journal of pharmaceutical analysis
Published: October 18, 2023
Corrigendum to "Erythropoietin ameliorates cognitive deficits by improving hippocampal and synaptic damage in streptozotocin-induced diabetic mice" [Cellular Signalling 106 (2023) 110614].
Journal: Cellular signalling
Published: September 11, 2023
"Erythropoietin ameliorates cognitive deficits by improving hippocampal and synaptic damage in streptozotocin-induced diabetic mice" [Cellular Signalling 106 (2023) 110614].
Journal: Cellular signalling
Published: September 07, 2023
Mollugin activates GLP-1R to improve cognitive dysfunction in type 2 diabetic mice.
Journal: Life sciences
Published: July 22, 2023
Schisandrin B, a potential GLP-1R agonist, exerts anti-diabetic effects by stimulating insulin secretion.
Journal: Molecular and cellular endocrinology
Published: May 23, 2023
Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: April 23, 2023
Erythropoietin ameliorates cognitive dysfunction in mice with type 2 diabetes mellitus via inhibiting iron overload and ferroptosis.
Journal: Experimental neurology
Published: February 08, 2023
Erythropoietin ameliorates cognitive deficits by improving hippocampal and synaptic damage in streptozotocin-induced diabetic mice.
Journal: Cellular signalling
Published: October 20, 2022
Erythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy.
Journal: Frontiers in pharmacology
Published: February 24, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026